CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer.
Aleksandra Semeniuk-WojtaśMagdalena ModzelewskaKarolina Poddębniak-StramaSylwia KołaczyńskaArkadiusz LubasBarbara GórnickaAnna JakiełaRafał StecPublished in: Cancers (2023)
cells in the tumor microenvironment, in addition to PD-L1 on tumor cells, facilitates the determination of a group of patients with a low risk of recurrence.